close

Enter

Log in using OpenID

Asthma Therapeutics Forecast up to 2020 in Major Developed Markets

embed
The analysis report includes complete market forecast up to 2020 for the major developed markets of North America, Europe and the Japan. It also discusses Asthma therapeutics in great detail with all the necessary pipeline analysis. Currently marke
[email protected]
Asthma Therapeutics Market Forecast up to 2020 in Major Developed
Economies
Summary: The analysis report includes complete market forecast up to 2020 for
the major developed markets of North America, Europe and the Japan. It also
discusses Asthma therapeutics in great detail with all the necessary pipeline
analysis. Currently marketed products, treatment algorithm, clinical trial results,
promising pipeline molecules, main drivers and barriers are also included in the
report.
The asthma therapeutics market is forecast to grow marginally over the forecast period
across the top eight developed nations, from $18.4 billion in 2013 to a projected value of
$21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%. This is in
spite of generic erosion facing several of the leading asthma brands, such as Advair
(fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol
fumarate) and Xolair (omalizumab), and is a consequence of new market entrants and
rising disease prevalence.
The global prevalence of asthma is significant, believed to affect approximately 300
million people worldwide. This burden is predicted to increase in future, reaching 400
million by 2025.
Although the majority of asthma patients are able to manage their symptoms effectively
using currently marketed products, some remain inadequately controlled with these
same products. This unmet need, coupled with rising global prevalence, has resulted in
strong industry interest.
Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in
“Asthma Therapeutics in Major Developed Markets to 2020 - Personalized
Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations”
Market Research Report at- http://www.marketreportsworld.com/asthmatherapeutics-in-major-developed-markets-to-2020-personalized-treatment-for-severeasthma-to-drive-market-growth-despite-patent-expirations-10070377
+1 408 520 9750
www.marketreportsworld.com
[email protected]
[email protected]
Consequently, the current asthma pipeline is highly innovative, featuring several
promising molecules in late-stage drug development. Biologics and monoclonal
antibodies, the latter in particular, are gaining prominence within the indication. Novel
monoclonal antibodies such as mepolizumab, reslizumab, lebrikizumab, and dupilumab
target Interleukins (IL), or IL receptors, and have demonstrated potential in severe and
inadequately controlled eosinophilic asthma, in turn representing a shift towards
personalized therapy. Despite the fact that they target only a small patient sub-set, they
are likely to be priced highly and to drive market growth, offsetting the impact of generic
erosion.
Scope of the report –
The report covers and includes –
- An introduction to asthma, including discussion of disease epidemiology, etiology
pathophysiology, symptoms, diagnosis, and treatment, with clinical data for drugs
featured in the current treatment algorithm discussed in detail.
- In-depth analysis of the current marketed products landscape, including product
profiles of the main drugs used and heat maps that compare their safety and efficacy
parameters.
- Comprehensive analysis of the asthma pipeline by phase of development, molecule
type, and molecular target and novelty, and comparative analysis of the most promising
late-stage pipeline drugs, as well as heat maps and a competitor matrix that compares
safety and efficacy parameters.
Get Sample of “Asthma Therapeutics in Major Developed Markets to 2020 Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent
Expirations” Market Research Report at http://www.marketreportsworld.com/enquiry/request-sample/10070377
- Additional in-depth analysis of the asthma clinical trials landscape, including trends in
size, duration and failure rate.
- Forecast projections for the asthma market to 2020, including analysis of the global
+1 408 520 9750
www.marketreportsworld.com
[email protected]
[email protected]
market and each of the eight major markets and incorporating projected, low, and highvariance scenarios based on treatment usage patterns and annual cost of therapy in
each of the major markets.
- Discussion of the strategic consolidations landscape, including trends in codevelopment and licensing deals relevant to asthma drug products.
The report will help in:
The report will assist business development and enable marketing executives to
strategize their product launches by allowing them to - Gain a comprehensive understanding of asthma, including diagnosis, disease severity,
and treatment algorithms
- Understand the current asthma marketed products landscape and recognize the
dominant therapeutic agents and pharmaceutical players involved
- Identify trends, developments, and prominent molecule types and molecular targets
within the asthma pipeline
- Gain an appreciation of the clinical and commercial aspects of the most promising
late-stage pipeline molecules and their potential competitive impact on the future
market.
Ask for Discount on “Asthma Therapeutics in Major Developed Markets to 2020 Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent
Expirations” Market Research Report at http://www.marketreportsworld.com/enquiry/request-discount/10070377
- Consider market opportunities and potential risks by examining trends in asthma
clinical trial size, duration and failure rate, phase of development, molecule type, and
molecular target
- Observe projections for treatment usage patterns, annual therapy costs, and market
growth in the eight major markets and understand reasons for variance in projected
patterns of growth.
About Market Reports World:
+1 408 520 9750
www.marketreportsworld.com
[email protected]
[email protected]
Market Reports World is the credible source for gaining the market research reports that
will exponentially accelerate your business. We are among the leading report resellers
in the business world committed towards optimizing your business. The reports we
provide are based on a research that covers a magnitude of factors such as
technological evolution, economic shifts and a detailed study of market segments.
Contact–
Mr. Ameya Pingaley
Market Reports World
+1-408 520 9750
Email – [email protected]
+1 408 520 9750
www.marketreportsworld.com
[email protected]
1/--pages
Report inappropriate content